SErIES IAEA HumAn HEAltH SErIES IAEA Hum

More documents

Recommendations

Info

Audit criteria Adequacy Comments Summary Information update protocol Y NI N NA Information distribution Y NI N NA 4.3.1.4. Patient education/consent Information availability and content Y NI N NA Policy and procedures for patient consent Y NI N NA Consent discussion Y NI N NA Compliance with consent policy and procedures Y NI N NA 92
Audit criteria Adequacy Comments Summary 4.3.1.5. Pre-procedure screening and preparation Policy and procedures for identifying ‘hazardous’ clinical conditions: e.g. allergies or renal impairment Y NI N NA Compliance with policy and procedures for hazardous clinical conditions Y NI N NA Policy and procedures for identifying ‘safety’ clinical conditions: e.g. age, infection or mobility relevant Y NI N NA Compliance with policy and procedures for clinical safety Y NI N NA Policy and procedures for examination specific preparation: fasting, etc. Y NI N NA 93
Page 1 and 2:
IAEA HumAn HEAltH SErIES no. 4 Comp
Page 3 and 4:
COMPREHENSIVE CLINICAL AUDITS OF DI
Page 5 and 6:
IAEA HUMAN HEALTH SERIES No. 4 COMP
Page 7 and 8:
FOREWORD The application of radiati
Page 9 and 10:
CONTENTS 1. INTRODUCTION . . . . .
Page 11 and 12:
5.1.3. Quality assurance processes
Page 13 and 14:
1. INTRODUCTION 1.1. CLINICAL AUDIT
Page 15 and 16:
1.1.3. Confidentiality of audits Co
Page 17 and 18:
evidence based medical research is
Page 19 and 20:
As a result of the comprehensive cl
Page 21 and 22:
The facility/institution is respons
Page 23 and 24:
2.4.2. Review The review process wi
Page 25 and 26:
2.5.1. Title page and contents page
Page 27 and 28:
2.6. DISSEMINATION OF THE REPORT Th
Page 29 and 30:
A QA committee should be establishe
Page 31 and 32:
Lines of authority should be reflec
Page 33 and 34:
—Medical support equipment such a
Page 35 and 36:
(g) (h) (i) Make an assessment of t
Page 37 and 38:
(c) (d) (e) (f) Examine the facilit
Page 39 and 40:
(c) (d) Consider policy in regard t
Page 41 and 42:
equire a written policy and procedu
Page 43 and 44:
Once examination scheduling has bee
Page 45 and 46:
Documentation of the details of the
Page 47 and 48:
There should be a radiographer resp
Page 49 and 50:
—Recorded; —Systematically eval
Page 51 and 52:
4.2.1.5. Pre-procedure screening an
Page 53 and 54: (f) (g) (h) (i) (j) (k) (l) (m) (n)
Page 55 and 56: 4.2.5. Report communication The aud
Page 57 and 58: —Digital image receptors (compute
Page 59 and 60: (b) (c) (d) Ensuring that appropria
Page 61 and 62: 5.1.2.2. Occupational and public ex
Page 63 and 64: (f) (g) Performance criteria for al
Page 65 and 66: Dosimetry for those subjected to ra
Page 67 and 68: 5.2.1.3. Management support The aud
Page 69 and 70: (b) (c) Discuss the facility’s po
Page 71 and 72: (g) (h) (i) Discuss with the medica
Page 73 and 74: Professionals engaging in such prog
Page 75 and 76: 6.2. THE AUDIT PROGRAMME 6.2.1. Edu
Page 77: (d) (v) Regularity of research meet
Page 80 and 81: Six months before audit Audited ins
Page 82 and 83: Day 1: Morning: All audit team memb
Page 84 and 85: Appendix III AUDIT REPORT FORMAT: S
Page 86 and 87: Appendix IV AUDIT REPORT FORMS The
Page 88 and 89: Audit criteria Adequacy Comments Su
Page 120 and 121: 5.3. AUDIT REPORT FORMS FOR TECHNIC
Page 136 and 137: 6.3. AUDIT REPORT FORMS FOR EDUCATI
Page 144 and 145: Appendix V NOTES ON PHYSICIST MEASU
Page 146 and 147: V.2.3. Other measurements The other
Page 148 and 149: [16] COMMISSION OF THE EUROPEAN COM
Page 151 and 152: Annex I APPLICATION FORM IAEA Clini
Page 153 and 154: Department Vision Statement and imm
Page 155 and 156:
List of equipment Equipment type Id
Page 157 and 158:
Annex II LIST OF ITEMS REQUESTED TO
Page 159 and 160:
Annex III EQUIPMENT-SPECIFIC CHECKL
Page 161 and 162:
Form RXR — Items to be reviewed b
Page 163 and 164:
Form RXR — Items to be reviewed b
Page 165 and 166:
Form FIF — Items to be reviewed b
Page 167 and 168:
FORM FOR A MAMMOGRAPHY QA PROGRAMME
Page 169 and 170:
Form MAM — Items to be reviewed b
Page 171 and 172:
Form CTQ — Items to be reviewed b
Page 173 and 174:
FORM FOR A SCREEN-FILM AND PROCESSO
Page 175 and 176:
FORM FOR A COMPUTED OR DIGITAL RADI
Page 177 and 178:
FORM FOR A VIEWING CONDITIONS (ANAL
Page 179 and 180:
FORM FOR A QA PROGRAMME FOR HARD CO
Page 181 and 182:
Form DPQ — Items to be reviewed b
Page 183 and 184:
FORM FOR A QA PROGRAMME FOR ULTRASO
Page 185 and 186:
FORM FOR A QA PROGRAMME FOR MRI For
Page 187 and 188:
Form MRI — Items to be reviewed b
Page 189 and 190:
TECHNIQUE OBSERVATION SHEET Radiogr
Page 191 and 192:
Tube focus to tabletop distance d F
Page 193 and 194:
K i Patient: Radiographic Calculati
Page 195 and 196:
Manufacturer of phantom: __________
Page 197 and 198:
P KA Patient: Fluoro 1 DETERMINATIO
Page 199 and 200:
Phantom: MGD 1 CALCULATION OF INCID
Page 201 and 202:
Phantom: CT1 MEASUREMENT OF C a,100
Page 203 and 204:
REFERENCE TO ANNEX IV [IV-1] INTERN
Page 205:
CONTRIBUTORS TO DRAFTING AND REVIEW
Page 208 and 209:
Korea, Republic of KINS Inc., Infor
show all

SErIES IAEA HumAn HEAltH SErIES IAEA Hum

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?